Medtronic RevElution Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 109 participants.

Also called NCT02480348

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 109 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02480348
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Australia, Brazil, Singapore (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02480348. Allocation not applicable; no masking; primary purpose treatment. Start 2015-12-03 (actual); primary completion 2017-06-16 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Medtronic RevElution Trial
Acronym
RevElution
Intervention (Device)
Polymer-free DES (Drug Eluting Stent)
Lead sponsor
Medtronic Vascular (class: industry)

Record details

Record id
cardio:ct-nct02480348
Content hash
3089a03d6b00be36643f2709838288b2479cc390dfca58bb056ed41ce4630556